PUBLISHER: The Business Research Company | PRODUCT CODE: 2106449
PUBLISHER: The Business Research Company | PRODUCT CODE: 2106449
Gelatin capsules are pharmaceutical delivery forms manufactured from gelatin or plant-derived substitutes that are used to contain medicines, dietary supplements, and nutraceutical ingredients. They are developed to provide accurate dosing in a stable, convenient, and highly bioavailable format while safeguarding active components from external influences such as moisture, oxygen exposure, and light.
The primary types of gelatin capsules consist of hard gelatin capsules and soft gelatin capsules. Hard gelatin capsules are two-piece capsule shells manufactured from gelatin and are widely utilized for enclosing powders, granules, and pellets intended for oral delivery. These capsules are produced using raw materials such as bovine gelatin, porcine gelatin, and other material sources. They serve functions including acting as a gelling agent, stabilizer and thickener, as well as a binding and texturizing agent, and are extensively applied in the nutraceutical and pharmaceutical industries.
Tariffs are influencing the gelatin capsules market by increasing the cost of imported raw materials such as bovine gelatin, porcine gelatin, and pharmaceutical-grade excipients used in capsule manufacturing, leading to higher production costs for pharmaceutical and nutraceutical companies. This is disrupting supply chains, particularly in import-dependent regions such as Asia-Pacific and Europe. Both hard gelatin and soft gelatin capsule segments are significantly affected due to reliance on cross-border sourcing of raw materials and encapsulation equipment. However, tariffs are also promoting local sourcing of raw materials, investment in regional capsule production facilities, and development of plant-based capsule alternatives, supporting long-term supply chain resilience and innovation.
The gelatin capsule market size has grown strongly in recent years. It will grow from $4.92 billion in 2025 to $5.27 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The historical-period growth can be attributed to expansion of pharmaceutical manufacturing and oral drug delivery systems, increasing demand for convenient dosage forms, rising use of gelatin capsules in vitamins and dietary supplements, growth in global generic drug production, and improvements in capsule manufacturing technologies and automation processes.
The gelatin capsule market size is expected to see strong growth in the next few years. It will grow to $7.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing demand for nutraceuticals and functional food products, growing shift toward plant-based and vegan capsule alternatives, rising adoption of precision medicine and controlled-release formulations, expansion of global pharmaceutical manufacturing capacity, and increasing focus on drug stability and bioavailability enhancement. Key trends in the forecast period include transition toward plant-based capsule materials replacing animal-derived gelatin, increasing adoption of modified-release capsule technologies for targeted drug delivery, rising demand for nutraceutical and dietary supplement encapsulation, integration of advanced coating technologies for moisture and oxygen protection, and growing use of high bioavailability capsule formulations in personalized medicine.
The growth of the pharmaceutical industry is expected to propel the growth of the gelatin capsule market going forward. The pharmaceutical industry refers to the sector involved in the research, development, production, and marketing of drugs used for medical treatment, prevention, and diagnosis of diseases. The expansion of the pharmaceutical industry is driven by the increasing prevalence of chronic and lifestyle-related diseases, which leads to higher demand for continuous drug development and treatment solutions. The pharmaceutical industry utilizes gelatin capsules as a reliable drug delivery system that improves stability, enhances bioavailability, ensures precise dosing, and increases patient compliance by making medicines easier to swallow and masking unpleasant tastes and odors. For instance, in April 2025, according to Eurostat, a Luxembourg-based government agency, in 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). At the same time, imports only recorded a modest increase of 0.5%, amounting to $112.7 billion (€119.7 billion). Therefore, the pharmaceutical industry is driving the growth of the gelatin capsule market.
Leading companies operating in the gelatin capsule market are focusing on developing innovative products, such as soft gelatin capsules to improve bioavailability, enhance patient compliance, and enable easier administration of medications across all age groups. Gelatin capsules are edible, biodegradable pharmaceutical dosage forms made from animal-derived gelatin or plant-based alternatives, designed to encapsulate liquid, semi-solid, or powdered drug formulations in a smooth, swallowable shell that dissolves rapidly in the digestive tract for efficient drug release. For example, in August 2024, Geneith Pharmaceuticals Limited, a Nigeria-based pharmaceutical company, launched Coatal Forte Soft Gelatin Capsules, a patient-friendly antimalarial formulation designed to improve treatment accessibility and effectiveness. The product is available in multiple strengths, including Coatal Gelatin Soft Gel 80/480 and 20/120, offering flexible dosing options to suit different patient needs. It is formulated to ensure faster drug delivery and improved therapeutic outcomes while maintaining affordability and ease of use, making it suitable for patients across all age groups and supporting better compliance in malaria treatment regimens.
In December 2023, Amneal Pharmaceuticals Inc., a US-based specialty pharmaceutical company engaged in gelatin capsule manufacturing, entered into a partnership with Strides Pharma Science Limited to jointly develop, manufacture, and supply icosapent ethyl acid soft gelatin capsules. Through this collaboration, both Amneal Pharmaceuticals and Strides Pharma Science Limited aim to strengthen their cardiovascular product portfolio, broaden access to affordable omega-3 fatty acid therapy for patients with elevated triglyceride levels, and reinforce their presence in the U.S. generic specialty pharmaceuticals segment. Strides Pharma Science Limited is an India-based pharmaceutical company involved in the development, manufacturing, and commercialization of a broad range of pharmaceutical products.
Major companies operating in the gelatin capsule market are Lonza Group (Capsugel), Catalent Inc., Aenova Group GmbH, HBI Eurocaps Ltd. (Ourvita Group), ACG Worldwide Pvt. Ltd., Suheung Co. Ltd., Procaps Group, Sirio Pharma Co. Ltd., Qualicaps (Roquette), CapsCanada Corporation, Farmacapsulas S.A., Natural Capsules Ltd., Sunil Healthcare Ltd., Erawat Pharma Limited, HealthCaps India Ltd., Jinan Gaohua Pharmaceutical Capsules Co. Ltd., Fortcaps Healthcare Ltd., Jiangsu Lefan Capsule Co. Ltd., Shanxi Guangsheng Medicinal Capsule Co. Ltd., Qingdao Yiqing Medicinal Capsules Co. Ltd., Roxlor LLC, Medi-Caps Ltd.
Asia-Pacific was the dominant region in the gelatin capsule market in 2025 and is expected to be the rapidly expanding region in the forecast period. The regions covered in gelatin capsule report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the gelatin capsule market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gelatin capsule market consists of sales of capsule shells, empty capsules, and vegetarian capsules (HPMC-based). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The gelatin capsule market research report is one of a series of new reports from The Business Research Company that provides gelatin capsule market statistics, including gelatin capsule industry global market size, regional shares, competitors with a gelatin capsule market share, detailed gelatin capsule market segments, market trends and opportunities, and any further data you may need to thrive in the gelatin capsule industry. This gelatin capsule market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gelatin Capsule Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses gelatin capsule market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for gelatin capsule ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gelatin capsule market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.